Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA. by Mieke L. M. Bentvelzen (21594442)

Risk of bias domains. by Cong Ding (3726178)

Subjects:

Risk of bias domains. by Cong Ding (3726178)

Subjects:

Evaluation of risk model. by Yajia Chen (20685780)

Subjects:

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

Forest plot of inflammatory markers. by Jin-Min Gu (17915039)

Subjects:

Relationship of risk score with immune status. by Yajia Chen (20685780)

Subjects:

S1 Data - Prognostic nomogram integrated with inflammatory marker ratios for assessing in-hospital mortality risk in patients with acute type A aortic dissection by Xiao-Chai Lv (22378891)

Subjects:

Expression of high-risk CRLs and co-expression CRGs in the GBM cuproptosis model. by Yajia Chen (20685780)

Subjects:

Data Sheet 1_Decrease in low-density lipoprotein cholesterol is associated with an increased risk of mortality in patients with diabetes mellitus.docx by Yun Gi Kim (9450226)

“…Thus, in patients with diabetes mellitus not receiving statin therapy, a decrease in LDL-cholesterol may be a surrogate marker for all-cause mortality and SCA.…”

GI-1d-a: Comparison of estimates of people for dataset A (left bar) and B (right bar) per region. The largest discrepancies occur in areas of NE, SE and SW Germany and adjacent reg... by Isabell Schmidt (6331013)

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

Risk of bias assessment for eligible randomized controlled trials. by Junyin Pan (20700411)

Subjects:

Quantitative real-time PCR analysis of high-risk CRLs and co-expressed CRGs in GBM human cell lines and the GBM mouse model. by Yajia Chen (20685780)

Subjects:

Innovation, nightlights and a continuous measure of city size. by Saul Estrin (8629173)

Drug concentrations for constructing a normal astrocyte cuproptosis model and expression of high-risk CRLs and co-expression CRGs in the human astrocyte cuproptosis model. by Yajia Chen (20685780)

Subjects:

Selection frequencies plotted in decreasing order. by Hannah P. Rowe (7830599)

Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)